Zobrazeno 1 - 10
of 298
pro vyhledávání: '"Kimihiro OKUBO"'
Publikováno v:
Allergology International, Vol 73, Iss 4, Pp 494-500 (2024)
In 2004, we started the initial attempt to evaluate the efficacy of SLIT for Japanese cedar pollinosis (JCP) using Japanese cedar (JC) pollen extract solution through a multicenter, placebo-controlled, double-blind comparative study. Based on its suc
Externí odkaz:
https://doaj.org/article/a342fa55a07e43c7a1dd664ebbdbed86
Publikováno v:
Brazilian Journal of Otorhinolaryngology, Vol 89, Iss 5, Pp 101292- (2023)
Objective: After Endoscopic Sinus Surgery (ESS), packing plays an important role in wound healing and hemostasis. However, the effect of the packing removal procedure on physician stress has not been evaluated. The purpose of this study was to evalua
Externí odkaz:
https://doaj.org/article/e8300c168f6f4952a810afbb18fbf2ae
Autor:
Mitsuhiro Okano, Shigeharu Fujieda, Minoru Gotoh, Yuichi Kurono, Atsushi Matsubara, Nobuo Ohta, Atsushi Kamijo, Takechiyo Yamada, Yuji Nakamaru, Mikiya Asako, Daiju Sakurai, Tetsuya Terada, Shuji Yonekura, Masafumi Sakashita, Kimihiro Okubo
Publikováno v:
Allergology International, Vol 72, Iss 1, Pp 41-53 (2023)
The Practical Guideline for the Management of Allergic Rhinitis, the fist guideline for allergic rhinitis in Japan, was prepared after a symposium held by the Japanese Society of Allergology in 1993. The current 9th edition was published in 2020 and
Externí odkaz:
https://doaj.org/article/6f7adef327494f1fa3e9f11ecfa7fc75
Autor:
Tomoya Kurokawa, MD, PhD, Syuji Yonekura, MD, PhD, Minoru Gotoh, MD, PhD, Mitsuhiro Okano, MD, PhD, Yuriko Maekawa, BSc, Kimihiro Okubo, MD, PhD, Yoshitaka Okamoto, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 2, Pp 100075- (2023)
Background: We previously demonstrated the efficacy of Japanese cedar (JC) pollen sublingual immunotherapy (SLIT) tablets for treating seasonal allergic rhinitis in a clinical trial (trial no. 206-2-1) that covered 5 pollen dispersal seasons from 201
Externí odkaz:
https://doaj.org/article/f8be57503f8c4b61b3602f5c6bc2d729
Autor:
Syuji Yonekura, Minoru Gotoh, Mitsuhiro Okano, Tomoya Kurokawa, Yuriko Maekawa, Kimihiro Okubo, Yoshitaka Okamoto
Publikováno v:
Allergology International, Vol 71, Iss 1, Pp 140-143 (2022)
Externí odkaz:
https://doaj.org/article/a557376cae76469ea046c26694aa2440
Autor:
Yasuyuki Nomura, Kimihiro Okubo, Tadashi Nakamura, Seiji Sawaki, Hideto Kitagou, Norio Idei, Shinya Kaneko, Satoko Kobayashi, Yusuke Tanaka, Yoshitaka Okamoto
Publikováno v:
Allergology International, Vol 70, Iss 1, Pp 96-104 (2021)
Background: There have been no reports of treatment effect persistence after long-term sublingual immunotherapy (SLIT) in patients with Japanese cedar (JC) pollinosis. Therefore, we conducted a post-marketing clinical trial to investigate the efficac
Externí odkaz:
https://doaj.org/article/ecbd063e6d684656a57bd76f96d642be
Publikováno v:
Immunity, Inflammation and Disease, Vol 8, Iss 3, Pp 333-341 (2020)
Abstract Background and Objective Nasal symptoms were reduced following allergen‐specific sublingual immunotherapy (SLIT) for allergic rhinitis. The mechanisms underlying the effectiveness of SLIT for Japanese cedar pollinosis are poorly understood
Externí odkaz:
https://doaj.org/article/ebe37154e515466d8f827ddf66dd358c
Publikováno v:
Immunity, Inflammation and Disease, Vol 8, Iss 3, Pp 258-266 (2020)
Abstract Background and objective Nasal symptoms of allergic rhinitis can be reduced with allergen‐specific subcutaneous immunotherapy (SCIT). However, the mechanisms underlying the effectiveness of SCIT for Japanese cedar pollinosis are not well u
Externí odkaz:
https://doaj.org/article/40a5ae7490964ebda4b8ab110f76476a
Autor:
Kimihiro Okubo, Yuichi Kurono, Keiichi Ichimura, Tadao Enomoto, Yoshitaka Okamoto, Hideyuki Kawauchi, Harumi Suzaki, Shigeharu Fujieda, Keisuke Masuyama
Publikováno v:
Allergology International, Vol 69, Iss 3, Pp 331-345 (2020)
Like asthma and atopic dermatitis, allergic rhinitis is an allergic disease, but of the three, it is the only type I allergic disease. Allergic rhinitis includes pollinosis, which is intractable and reduces quality of life (QOL) when it becomes sever
Externí odkaz:
https://doaj.org/article/5cb4b065bbce426990bf1def85bd16be
Autor:
Yoshimichi Okayama, Hisako Matsumoto, Hiroshi Odajima, Shunsuke Takahagi, Michihiro Hide, Kimihiro Okubo
Publikováno v:
Allergology International, Vol 69, Iss 2, Pp 167-177 (2020)
IgE and mast cells play a pivotal role in various allergic diseases, including asthma, allergic rhinitis, and urticaria. Treatment with omalizumab, a monoclonal anti-IgE antibody, has significantly improved control of these allergic diseases and intr
Externí odkaz:
https://doaj.org/article/ea97d8aa88c441809cc4cb59e963fdf0